Stock Performance and Market Context
The stock opened sharply lower by 5.00% today, continuing its losing streak for the 21st consecutive day. Intraday trading saw the price remain at the low of Rs.47.33, with no recovery throughout the session. This level represents a steep fall from its 52-week high of Rs.379, reflecting a total decline of approximately 87.5% over the past year.
Trident Texofab’s performance has notably underperformed its sector and broader market benchmarks. The stock lagged the Garments & Apparels sector by 4.58% today and has generated a negative return of -73.41% over the last 12 months, compared to a modest 1.82% gain in the Sensex during the same period.
Market-wide conditions have also been challenging, with the Sensex itself declining by 1.18% today to 75,134.55, edging closer to its own 52-week low of 71,425.01. The benchmark index is trading below its 50-day moving average, which itself is positioned below the 200-day moving average, signalling a bearish market environment.
Technical Indicators Confirm Bearish Momentum
Technical analysis of Trident Texofab reveals a predominantly bearish outlook. The stock is trading below all key moving averages—5-day, 20-day, 50-day, 100-day, and 200-day—indicating sustained downward pressure. Weekly and monthly MACD readings are bearish or mildly bearish, while Bollinger Bands also suggest a bearish trend on both weekly and monthly timeframes.
Other momentum indicators such as the KST and Dow Theory assessments align with this negative sentiment, showing mild to moderate bearishness. The Relative Strength Index (RSI) on a weekly basis is one of the few indicators showing bullish tendencies, but this has not translated into price recovery so far.
Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!
- - Sustainable profitability reached
- - Post-turnaround strength
- - Comeback story unfolding
Fundamental Metrics and Financial Health
From a fundamental perspective, Trident Texofab’s long-term financial strength remains subdued. The company’s average Return on Capital Employed (ROCE) stands at 6.88%, which is considered weak relative to industry standards. This limited capital efficiency is compounded by a high Debt to EBITDA ratio of 6.83 times, indicating a constrained ability to service debt obligations comfortably.
Quarterly results for December 2025 showed net sales at Rs.25.74 crore, marking the lowest quarterly sales figure in recent periods. This flat revenue performance adds to concerns about the company’s near-term growth trajectory.
Over the past three years, the stock has consistently underperformed the BSE500 index across multiple time horizons—three years, one year, and three months—highlighting persistent challenges in delivering shareholder value.
Valuation and Profitability Considerations
Despite the weak price performance, some valuation metrics suggest the stock is trading at a discount relative to its peers. The company’s ROCE of 7.4% and an Enterprise Value to Capital Employed ratio of 1.2 indicate an attractive valuation on a capital efficiency basis. Furthermore, the company’s profits have risen by 122.5% over the past year, even as the stock price declined sharply, resulting in a low PEG ratio of 0.5.
However, these valuation positives have not translated into price support, as the stock remains classified with a Mojo Score of 23.0 and a Mojo Grade of Strong Sell, downgraded from Sell on 3 February 2026. The micro-cap status of the company also adds to liquidity and volatility considerations.
Holding Trident Texofab Ltd from Garments & Apparels? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!
- - Peer comparison ready
- - Superior options identified
- - Cross market-cap analysis
Shareholding and Market Position
The majority of Trident Texofab’s shares are held by non-institutional investors, which may contribute to higher volatility and lower institutional support. The company operates within the Garments & Apparels sector, which has faced mixed market conditions in recent months, further complicating the stock’s performance dynamics.
Given the current trading levels, the stock remains significantly below all key moving averages, reflecting a lack of upward momentum. The persistent decline over the last three weeks and the recent 52-week low underscore the challenges faced by the company in regaining investor confidence.
Summary of Technical and Fundamental Outlook
In summary, Trident Texofab Ltd’s stock has experienced a marked decline to Rs.47.33, its lowest level in a year, amid a combination of subdued financial metrics, elevated leverage, and a bearish technical setup. While some valuation indicators suggest the stock is trading at a discount, the overall market and sector conditions, coupled with the company’s financial profile, have contributed to the sustained downward trend.
Investors observing the stock will note the extended period of price weakness, with the stock underperforming both its sector and the broader market indices. The downgrade to a Strong Sell grade by MarketsMOJO on 3 February 2026 reflects these ongoing concerns.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
